Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05784753 · ClinicalTrials.gov registry record · NA
HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection Fraction
A NA study of HFpEF - Heart Failure With Preserved Ejection Fraction, sponsored by University of Nebraska.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 3
- Study locations
NCT05784753 is a NA study of HFpEF - Heart Failure With Preserved Ejection Fraction that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 300 participants, below the 9,831-participant average among 6 other HFpEF - Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT05784753, a NA study of HFpEF - Heart Failure With Preserved Ejection Fraction, is actively recruiting participants, sponsored by University of Nebraska.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this study is to learn more about patients with heart failure with preserved ejection fraction (HFpEF) and exercise. Investigators want to see if meeting with a coach in person or by video conference will help these patients exercise, feel better, and change markers in their blood. Participants will be randomly placed in one of three groups for 18 months. All groups will have access to a fitness center and be given a watch and heart rate monitor to wear during exercise. The usual care group (control group) will have access to exercise videos via the medical fitness center and will not meet with a coach. The HEART Camp group will exercise and meet with their coach in-person at the medical fitness center. The HEART Camp Connect group will have access to exercise videos via the medical fitness center and will meet with their coach via videoconferencing. All participants will take part in an exercise test and study training prior to being randomized. At four data collection time points, participants will wear an activity monitor for 7 days each, have their blood drawn, and answer questions related to heart failure and exercise. Participants will also wear a heart rate monitor when they exercise and fill out a daily exercise diary.
Conditions Studied
Interventions
- BEHAVIORAL HEART Camp
- BEHAVIORAL HEART Camp Connect
Study Locations (3)
Michigan
- Henry Ford Health System - Detroit
Nebraska
- University of Nebraska Medical Center - Omaha
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-11-20 |
| Est. Completion | 2028-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05784753
The ClinicalTrials.gov registry entry for NCT05784753 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,831-participant average among 6 other HFpEF - Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (97% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HFpEF - Heart Failure With Preserved Ejection Fraction appearing as the primary indexed condition, and to 2 interventions - of which HEART Camp is the first listed.
NCT05784753 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Michigan, Nebraska, Virginia.
Frequently Asked Questions
What is clinical trial NCT05784753 about?
NCT05784753 is a clinical study titled "HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection Fraction". The goal of this study is to learn more about patients with heart failure with preserved ejection fraction (HFpEF) and exercise. Investigators want to see if meeting with a coach in person or by video conference will help these patients exercise, feel better, and change markers in their blood. Parti...
What is the current status of trial NCT05784753?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2023-11-20. Estimated completion is 2028-03.
What conditions does trial NCT05784753 study?
This clinical trial studies the following conditions: HFpEF - Heart Failure With Preserved Ejection Fraction.
What interventions are being tested in trial NCT05784753?
The interventions under investigation include: HEART Camp (BEHAVIORAL), HEART Camp Connect (BEHAVIORAL).
Who is sponsoring clinical trial NCT05784753?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05784753 being conducted?
This trial has 3 study locations across Michigan, Nebraska, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HFpEF - Heart Failure With Preserved Ejection Fraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MOVE-HF MOtivating Physical Activity With BehaVioral Economics in Heart Failure With Preserved Ejection Fraction
RECRUITING · NA
-
US Benchmarking Clinical Study
RECRUITING
-
Tailored Exercise Training Study Among Adults With HFpEF
RECRUITING · Phase 2
-
Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension
RECRUITING · Phase 2
-
CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation
RECRUITING · Phase 2
-
Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.